Tendon healing: Many studies have found BPC-157 to be effective in treating tendon injuries: A small study in humans found that injecting BPC-157 directly into the knee joint helps with different types of knee pain
Kenneth McCall, published a paper in 2025 finding that compounded GLP-1s were linked to higher rates of adverse effects than non-compounded products between 2018 and 2024, including more abdominal pain, diarrhea, and nausea
"Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications." Curr Neuropharmacol
BPC-157 from Eternal Peptides is sold exclusively for laboratory research purposes and is not for human or veterinary use, clinical administration, or therapeutic application
A study published in ScienceDirect on transected sciatic nerve models demonstrated that BPC-157-treated groups exhibited faster axonal regeneration, improved neural fascicle presentation, and higher density of regenerative fibers compared to untreated controls